Fulgent Genetics (FLGT): Utang-utang marang kapitalisasi buku

Tandha merek Fulgent Genetics Inc (FLGT)

Fulgent Genetics, Inc. (FLGT) is implementing eco-friendly digital protocols in genetics while maintaining strict control over waste disposal. Efficient logistics for transporting biomaterials to central hubs accelerate diagnostic turnaround times. The business relies on oncology diagnostics and IT solutions, resulting in a metric of 0.01. This price chart for the shares of the company, which specializes in laboratory health screening, is provided below.

FLGT Rasio utang marang nilai buku Fulgent (04.07.2022 - 28.10.2026)

Ringkesan rincian data analitis Fulgent Genetics Inc (FLGT)

- rega lan prakiraan konsensus rega:
Rega saham Fulgent Genetics, Inc.|FLGT - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar Fulgent|FLGT - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham Fulgent Genetics|FLGT - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku fulgentgenetics.com|FLGT - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas Fulgent Genetics, Inc.|FLGT - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Fulgent Corp|FLGT - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Fulgent
Ringkesan analitik perusahaan:Fulgent Genetics, Inc.
Produk asli Fulgent

Fulgent Genetics, Inc. (FLGT) is generating a steady cash flow to service its obligations through the diversification of its oncology diagnostics services and contracts with US clinics. By analyzing the ratio of financial debt to book capitalization, investors assess the proportion of borrowed funds within the equity structure, where a decrease in this coefficient confirms the issuer's financial stability and minimizes bankruptcy risks during market downturns.

Pesaing Fulgent Genetics, Inc.

A - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku questdiagnostics.com DGX|Illumina - Utang-utang marang kapitalisasi buku|EXAS: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku PerkinElmer|Bio-Rad Corp (BIO) - Rasio utang marang nilai buku|NNNN (Anbio Biotechnology) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku SHC|Rasio utang marang kapitalisasi buku QuidelOrtho Corporation (QDEL)|Rasio utang marang kapitalisasi buku OPKO Health Inc OPK|CDNA: Utang marang nilai buku|Maravai - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku LAB (Standard BioTools Inc.)|CTKB - Utang-utang marang aset resik|OraSure - Utang-utang marang kapitalisasi buku|XGN (Exagen) - Utang-utang marang aset resik|MDXH: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Lucid Diagnostics, Inc|PRE - Utang-utang marang kapitalisasi buku|Rasio utang-utang marang kapitalisasi buku imdxinc.com IMDX|Utang marang nilai buku TRIB (Trinity Biotech)|ProPhase Labs Inc - Utang-utang marang kapitalisasi buku|AIMD - Rasio utang marang kapitalisasi buku|CODX - Rasio utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku HSCS (Heart Test Laboratories)|biomerica.com (BMRA) - Utang marang aset resik|Utang-utang marang kapitalisasi buku CDIO (Cardio Diagnostics Holdings Inc.)|Utang-utang marang nilai buku VRAX|Rasio utang marang kapitalisasi buku Bluejay BJDX|Rasio utang marang nilai buku Aspira Women's Health Inc AWH|Utang marang nilai buku Accelerate Diagnostics (AXDX)|CNTG - Utang marang modal buku|Utang marang nilai buku Enzo (ENZ)|FRES - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku GENE (gtglabs.com)|23andMe Inc (ME) - Utang marang aset resik|Utang-utang marang kapitalisasi buku PMD (Psychemedics)